Israel Pediatric Vaccines Market (2025-2031) | Growth, Value, Competitive Landscape, Companies, Share, Analysis, Size & Revenue, Industry, Outlook, Trends, Segmentation, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Pediatric Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 Israel Pediatric Vaccines Market - Industry Life Cycle

3.4 Israel Pediatric Vaccines Market - Porter's Five Forces

3.5 Israel Pediatric Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Pediatric Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 Israel Pediatric Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing diseases among children

4.2.2 Government initiatives and funding to promote pediatric vaccination programs

4.2.3 Growing prevalence of infectious diseases in children driving demand for vaccines

4.3 Market Restraints

4.3.1 High costs associated with pediatric vaccines affecting affordability for some segments of the population

4.3.2 Limited accessibility to healthcare facilities in rural or remote areas hindering vaccine distribution and coverage

6.1 Israel Pediatric Vaccines Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Pediatric Vaccines Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Pediatric Vaccines Market Revenues & Volume, By Monovalent, 2021- 2031F

6.1.4 Israel Pediatric Vaccines Market Revenues & Volume, By Multivalent, 2021- 2031F

6.2 Israel Pediatric Vaccines Market, By Technology

6.2.1 Overview and Analysis

6.2.2 Israel Pediatric Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F

6.2.3 Israel Pediatric Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F

6.2.4 Israel Pediatric Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F

6.2.5 Israel Pediatric Vaccines Market Revenues & Volume, By Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2021- 2031F

6.3 Israel Pediatric Vaccines Market, By Indication

6.3.1 Overview and Analysis

6.3.2 Israel Pediatric Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F

6.3.3 Israel Pediatric Vaccines Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F

6.3.4 Israel Pediatric Vaccines Market Revenues & Volume, By Measles, Mumps and Rubella, 2021- 2031F

6.3.5 Israel Pediatric Vaccines Market Revenues & Volume, By Meningococcal Disease, 2021- 2031F

6.3.6 Israel Pediatric Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F

6.3.7 Israel Pediatric Vaccines Market Revenues & Volume, By Polio, 2021- 2031F

6.3.8 Israel Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F

6.3.9 Israel Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F

7.1 Israel Pediatric Vaccines Market Export to Major Countries

7.2 Israel Pediatric Vaccines Market Imports from Major Countries

8.1 Immunization coverage rate among children under the age of five

8.2 Number of pediatric vaccine doses administered annually

8.3 Percentage of pediatric population receiving recommended vaccinations as per schedule

9.1 Israel Pediatric Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Pediatric Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 Israel Pediatric Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 Israel Pediatric Vaccines Market Revenue Share, By Companies, 2024

10.2 Israel Pediatric Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters